Medicover AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
229.00
269.00
205.00
1,448.00
390.00
372.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-205.00
-165.00
-421.00
-415.00
-7.00
-248.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
2,379.00
1,865.00
1,484.00
2,009.00
1,483.00
794.00
Cash Flow from Investing Activities
-2,558.00
-1,473.00
-2,058.00
-3,410.00
-1,350.00
-1,548.00
Cash Flow from Financing Activities
397.00
-259.00
159.00
1,880.00
30.00
693.00
Net Cash Inflow / Outflow
217.00
119.00
-441.00
357.00
124.00
-38.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-2.00
-12.00
-27.00
-121.00
-38.00
22.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Medicover AB
Figures in Million
consolidated Cash Flow Results
Change(SEK)
Change(%)
Profit Before Tax
229.872147940998
405
-176.00
-43.24%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-205.855654872535
44
-249.00
-567.85%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
2379.92009883192
1095
1,284.00
117.34%
Cash Flow from Investing Activities
-2558.32833305479
-386
-2,172.00
-562.78%
Cash Flow from Financing Activities
397.987599420235
-682
1,079.00
158.36%
Net Cash Inflow / Outflow
217.292080143232
59
158.00
268.29%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-2.28728505413928
32
-34.00
-107.15%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 27.61% vs 25.61% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
2,379.92
1,865.02
27.61%






